8Booth CM, Matukas LM, Tomlinson GA, et al. Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area. JAMA. 2003 ; 289 : 1 - 9.
9Zhong N S, Zeng G Q. Our Strategies for Fighting Severe Acute Respiratory Syndrome (SARS). Am J Respir Crit Care Med. Published online, 2003,28.
二级参考文献11
1Bernard GR, Artigas, Brighan KL, et al. Report of the american european consensus conference on ARDS :definitions, mechanism,relevant outcomes and clinical trial coordinations. Intensive Care Med, 1994 ,20:225-232.
2Saikku P. Atypical respiratory pathogen. Clin Microbiol Infect, 1997,3:599-604.
3Lee SJ, Lee MG, Jeon MJ, et al. Atypical pathogens in adult patients admitted with community-acquired pneumonia in Korea. Jpn J Infect Dis, 2002 ,55:157-159.
4Chan PK. Outbreak of avian influenza A( H5N1 ) virus infection in Hong Kong in 1997. Clin Infect Dis, 2002 1 ;34 Suppl 2:S58-64.
5Yuen KY, Chan PKS, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet, 351:467-471.
6Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Eng J Med, www. nejm.org. on March 31,2003.
7Ksiazek TG, Erdman D, Goldsmith C et al. A novel coronavirus associated with severe acute respiratory syndrome. New Eng J Med2003, April 10th www. nejm. org
8Peiris JSM, Lai ST, Poon, LLM et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 2003, 361:9366.
9Osterhaus A. Severe acute respiratory syndrome- WHO press briefing Palais des Nation, 16th April 2003 www. who. int/csr/sars/2003.
10Peers SH. The role of lipocortin in corticosteroid actions. Am Rev Respir Dis, 1990, 141(2 Pt 2):18.
